Claim6214751c3b5714e9952dad159f6255a841a18524688b7559b49fad440ce1e54a·My Arguments

Claim

Evidence beyond roughly four years, and in younger or low-cardiovascular-risk populations, remains thin, and at least one meta-analysis reports an unresolved pancreatitis signal (RR ~1.44) that attenuates after adjustment — so the favorable balance is established for high-cardiovascular-risk adults over a multi-year horizon, not proven for indefinite use across all populations.

Evidence (1)

Rates of pancreatitis and pancreatic cancer among GLP-1 receptor agonists: systematic review and meta-analysis of RCTs
Reports an overall elevated pancreatitis RR (~1.44) that loses significance on stratification, and notes limited very-long-term data.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12457091/

Embed this claim

<iframe
  src="https://www.isonomia.app/embed/claim/6214751c3b5714e9952dad159f6255a841a18524688b7559b49fad440ce1e54a"
  width="600"
  height="280"
  frameborder="0"
  style="border: 1px solid #e5e7eb; border-radius: 8px;"
  title="Isonomia Claim"
  loading="lazy"
></iframe>

Copy and paste into any website or forum that supports HTML.

Respond to this claim on Isonomia

Build or challenge arguments with structured reasoning in the Digital Agora.

View full deliberationJoin & respond